Efficacy of lanreotide in early-stage duodeno-pancreatic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1 (MEN1): preliminary data

被引：0
|
作者：
Ramundo, V. [1 ]
Marciello, F. [1 ]
Marotta, V. [1 ]
Modica, R. [1 ]
Del Prete, M. [1 ]
Camera, L. [1 ]
Napolitano, V. [2 ]
De Luca, L. [3 ]
Colao, A. [1 ]
Faggiano, A. [1 ]
机构：
[1] Univ Naples Federico II, Naples, Italy
[2] Univ Naples 2, Naples, Italy
[3] Pellegrini Hosp, Naples, Italy
来源：
WIENER KLINISCHE WOCHENSCHRIFT | 2014年 / 126卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P39
引用
收藏
页码：S161 / S161
页数：1
相关论文
共 50 条
  • [1] Efficacy of Lanreotide versus Follow-Up in Early-Stage Duodeno-Pancreatic Neuroendocrine Tumors (NETs) Related to Multiple Endocrine Neoplasia Type 1 (MEN1): Preliminary Data
    Ramundo, V
    Marciello, F.
    Modica, R.
    Marotta, V
    Pizza, G.
    Camera, L.
    Napolitano, V
    De Luca, L.
    Colao, A.
    Faggiano, A.
    NEUROENDOCRINOLOGY, 2015, 102 (1-2) : 125 - 125
  • [2] Survival and Prognosis in Patients with Duodeno-Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1 Syndrome
    Modica, R.
    Lo Calzo, F.
    De Cicco, F.
    Bottiglieri, F.
    Sciammarella, C.
    Colao, A.
    Faggiano, A.
    NEUROENDOCRINOLOGY, 2018, 106 : 108 - 108
  • [3] Duodeno Pancreatic Neuroendocrine Tumors (DPNET) in Multiple Endocrine Neoplasia Type 1 (MEN1): An Italian Restrospective, Observational, Multicenter Study
    Modica, R.
    Davi, M., V
    Brighi, N.
    Massironi, S.
    Pusceddu, S.
    Zatelli, M. C.
    Albertelli, M.
    Malandrino, P.
    De Luca, I
    Grimaldi, F.
    Colao, A.
    Faggiano, A.
    NEUROENDOCRINOLOGY, 2019, 108 : 82 - 82
  • [4] Impact of Long-Acting Octreotide in Patients with Early-Stage MEN1-Related Duodeno-Pancreatic Neuroendocrine Tumors
    Ramundo, V
    Del Prete, M.
    Marotta, V
    Marciello, F.
    Camera, L.
    Circelli, L.
    Colantuoni, V
    Di Sarno, A.
    Carratu, A. C.
    De Luca di Roseto, C.
    Colao, A.
    Faggiano, A.
    NEUROENDOCRINOLOGY, 2014, 99 (3-4) : 273 - 274
  • [5] Impact of long-acting octreotide in patients with early-stage MEN1-related duodeno-pancreatic neuroendocrine tumours
    Ramundo, V.
    Del Prete, M.
    Marotta, V.
    Marciello, F.
    Camera, L.
    Napolitano, V.
    De Luca, L.
    Circelli, L.
    Colantuoni, V.
    Di Sarno, A.
    Carratu, A. C.
    di Roseto, C. de Luca
    Colao, A.
    Faggiano, A.
    CLINICAL ENDOCRINOLOGY, 2014, 80 (06) : 850 - 855
  • [6] Multiple endocrine neoplasia type 1 (MEN1): Not only inherited endocrine tumors
    Falchetti, Alberto
    Marini, Francesca
    Luzi, Ettore
    Giusti, Francesca
    Cavalli, Loredana
    Cavalli, Tiziana
    Brandi, Maria Luisa
    GENETICS IN MEDICINE, 2009, 11 (12) : 825 - 835
  • [7] ARMC5 Alterations in Patients With Sporadic Neuroendocrine Tumors and Multiple Endocrine Neoplasia Type 1 (MEN1)
    Damjanovic, Svetozar S.
    Antic, Jadranka A.
    Elezovic-Kovacevic, Valentina, I
    Dundjerovic, Dusko M.
    Milicevic, Ivana T.
    Beleslin-Cokic, Bojana B.
    Ilic, Bojana B.
    Rodic, Gordana S.
    Berthon, Annabel
    Maria, Andrea Gutierrez
    Faucz, Fabio R.
    Stratakis, Constantine A.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (12):
  • [8] Growth velocity of small, asymptomatic neuroendocrine pancreatic tumors in patients with multiple endocrine neoplasia type 1 (MEN1) as determined by endosonographic imaging
    Ivan, D
    Bartsch, DK
    Langer, P
    Meyer, S
    Klose, KJ
    Behr, T
    von Mach, MA
    Kann, PH
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2005, 152
  • [9] Multiple endocrine neoplasia type 1 (MEN1)
    Marx, Stephen J.
    ENDOCRINE JOURNAL, 2010, 57 : S211 - S211
  • [10] Multiple endocrine neoplasia type 1 (MEN1)
    Carroll, Richard W.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 (04) : 297 - 309
12345